Rapid Dose Therapeutics Corp. approved the election of Donald Sheldon as director of the company, at its annual general and special meeting of shareholders held on December 6, 2019. The company also announced that Ian Fodie, the current Chief Financial Officer of the company, has resigned with an ending date of December 10, 2019.

Effective December 11, 2019, Miles Nagamatsu will be re-joining the company as the interim Chief Financial Officer. Miles Nagamatsu served as Chief Financial Officer of ACME Resources Inc. Effective immediately, the company is also announced the appointment of Kristina Shea as Corporate Secretary, bringing over 20 years of financial and marketing communications. Her experience includes engagement with shareholders, vendors, suppliers and community stakeholders.

The company announced that Brian Howlett and Jason Lewis, who are stepping down from the board. Jason Lewis will be focusing his efforts on his management role of SVP, Business Development.